Amino Acid Metabolism Practice Questions

Q: A 5-year-old girl with global developmental delay, hypotonia, and failure to thrive presents with severe hyperammonemia. Laboratory results show increased orotic acid, increased glutamine, and decreased BUN. Evaluate and determine the underlying metabolic disorder.

Ornithine transcarbamylase deficiency (OTC deficiency). ***Ornithine transcarbamylase deficiency (OTC deficiency)*** - **Hyperammonemia** with **increased orotic acid** and **decreased BUN** is the hallmark of OTC deficiency, an X-linked urea cycle disorder. - The deficiency in OTC prevents the conversion of carbamoyl phosphate and ornithine to citrulline, leading to the accumulation of carbamoyl phosphate which then enters the **pyrimidine synthesis pathway**, increasing orotic acid. *Maple syrup urine disease (MSUD)* - While it presents with **developmental delay** and **poor feeding**, MSUD is characterized by the accumulation of **branched-chain amino acids** (leucine, isoleucine, valine) and their ketoacids, not hyperammonemia with increased orotic acid. - The urine has a characteristic sweet smell, resembling **maple syrup**. *Phenylketonuria (PKU)* - PKU is caused by a deficiency in **phenylalanine hydroxylase**, leading to the accumulation of phenylalanine. - It does not present with **hyperammonemia** or **orotic aciduria**; instead, it causes severe intellectual disability if untreated and is often detected by newborn screening. *Methylmalonic acidemia (MMA)* - MMA is an organic aciduria characterized by the accumulation of **methylmalonic acid** due to a defect in methylmalonyl-CoA mutase or its cofactor vitamin B12 metabolism. - Patients typically present with metabolic acidosis, hypoglycemia, elevated propionic acid, and ketonuria, but **hyperammonemia and orotic aciduria are not primary features**.

Q: Ochronosis is due to the accumulation of?

Homogentisic acid. ***Homogentisic acid (Correct)*** - **Ochronosis** is a rare genetic disorder characterized by the accumulation of **homogentisic acid** in connective tissues. - This accumulation results from a deficiency of the enzyme **homogentisate 1,2-dioxygenase**, which is crucial in the catabolism of tyrosine and phenylalanine. - Clinically presents with dark pigmentation of cartilage, sclera, and other connective tissues. *Alkapton (Incorrect)* - While **alkaptonuria** is the disease caused by homogentisic acid accumulation, **alkapton** itself is not the substance that accumulates in tissues in ochronosis. - **Alkapton** refers to the dark-colored urine observed in patients with alkaptonuria, which is due to the oxidation of homogentisic acid in the urine. *Xanthurenate (Incorrect)* - **Xanthurenate** is an intermediate in the metabolism of tryptophan, and its accumulation is associated with certain vitamin B6 deficiencies. - It is not involved in the pathogenesis of ochronosis or alkaptonuria. *Glyoxylate (Incorrect)* - **Glyoxylate** is a metabolic intermediate involved in various pathways, including carbohydrate and amino acid metabolism. - Accumulation of glyoxylate is associated with **primary hyperoxaluria type 1**, but not with ochronosis.

Q: What is the primary methyl donor in the conversion of norepinephrine to epinephrine?

S-adenosyl methionine. ***S-adenosyl methionine*** (SAM) - **S-adenosyl methionine (SAM)** is the universal methyl donor in many biological methylation reactions, including the conversion of **norepinephrine to epinephrine**. - The enzyme **phenylethanolamine N-methyltransferase (PNMT)** uses SAM to transfer a methyl group to norepinephrine, forming epinephrine. *Arginine* - **Arginine** is an amino acid primarily involved in the synthesis of **nitric oxide**, urea, and creatine, and does not serve as a direct methyl donor. - Its metabolic roles are distinct from methylation processes involving catecholamines. *Phenylalanine* - **Phenylalanine** is an essential amino acid that is a **precursor to tyrosine**, which is then used to synthesize catecholamines like dopamine, norepinephrine, and epinephrine. - It is a building block in the synthesis pathway but does not directly donate methyl groups. *Methionine* - **Methionine** is an essential amino acid that is converted to **S-adenosyl methionine (SAM)** through the action of methionine adenosyltransferase. - While methionine is the precursor to SAM, it is **SAM itself that serves as the active methyl donor**, not free methionine.

Q: Phenylketonuria is due to deficiency of:

Phenylalanine hydroxylase (PAH). ***Phenylalanine hydroxylase (PAH)*** - **Phenylketonuria (PKU)** is an inherited metabolic disorder caused by a deficiency of the enzyme **phenylalanine hydroxylase (PAH)**. - This enzyme is crucial for converting the amino acid **phenylalanine** into **tyrosine**, and its deficiency leads to an accumulation of phenylalanine in the body. - PKU follows an **autosomal recessive** inheritance pattern. *Phenylalanine (amino acid)* - While **phenylalanine** accumulates to toxic levels in PKU, it is the substrate, not the deficient component. - The disease stems from the body's inability to metabolize this amino acid due to the enzyme deficiency. *Tyrosine* - **Tyrosine** is the product of the reaction catalyzed by PAH, and its production is limited in PKU. - However, the deficiency of tyrosine is a secondary effect, not the primary cause of PKU. *None of the options* - This option is incorrect because the deficiency of **phenylalanine hydroxylase (PAH)** is precisely the cause of Phenylketonuria.

Q: In which condition is Vanillylmandelic Acid (VMA) excreted in urine?

Pheochromocytoma. ***Pheochromocytoma*** - **Vanillylmandelic Acid (VMA)** is a breakdown product of catecholamines (epinephrine and norepinephrine), which are overproduced in **pheochromocytoma** [2]. - Elevated VMA levels in urine are a key diagnostic marker for this **adrenal medulla tumor** [3]. *Alkaptonuria* - This is an inherited disorder of **tyrosine metabolism**, leading to the accumulation of **homogentisic acid**. - It causes **ochronosis** (darkening of cartilage and connective tissue) and dark urine upon standing, but not elevated VMA. *Neuroblastoma* - While neuroblastoma also involves **catecholamine overproduction**, it typically leads to elevated levels of **homovanillic acid (HVA)** and **VMA**, but is primarily characterized by HVA in children. - Neuroblastoma is a childhood cancer, distinct from the adrenal tumor seen in adults with pheochromocytoma. *Cushing's syndrome* - This condition is characterized by chronic **excess cortisol** production, leading to symptoms like central obesity, moon facies, and hypertension [1]. - It does not involve alterations in catecholamine metabolism or elevated VMA levels.

Q: Amino acid metabolism is implicated in which disease?

Maple syrup urine disease. ***Maple syrup urine disease*** - This disease is a genetic disorder of **amino acid metabolism**, specifically the breakdown of **branched-chain amino acids** (leucine, isoleucine, and valine). - Its characteristic odor, resembling **maple syrup**, is due to the accumulation of these amino acids and their ketoacids in bodily fluids. *Reye's syndrome* - This is an acute encephalopathy and **liver dysfunction**, typically affecting children, often linked to aspirin use during viral infections. - It primarily involves **mitochondrial damage** and fatty infiltration of the liver, not a direct amino acid metabolism defect. *Von Gierke's disease* - This is a type of **glycogen storage disease (Type I)** caused by a deficiency in **glucose-6-phosphatase**. - It leads to an inability to release glucose from stored glycogen in the liver and kidneys, resulting in **hypoglycemia** and hepatomegaly, not amino acid metabolism issues. *McArdle's disease* - This is another **glycogen storage disease (Type V)**, characterized by a deficiency in **muscle phosphorylase**. - Patients experience exercise intolerance, muscle pain, and cramping due to the inability to break down muscle glycogen for energy, unrelated to amino acid metabolism.

Q: Albinism is due to deficiency of the following enzyme?

Tyrosinase. ***Tyrosinase*** - **Albinism** is characterized by a lack of melanin production, which is primarily due to a defect in the enzyme **tyrosinase**. - **Tyrosinase** is crucial for converting **tyrosine** into **DOPA**, a key step in the biosynthesis of melanin. *Phenylalanine hydroxylase* - Deficiency of **phenylalanine hydroxylase** leads to **phenylketonuria (PKU)**, an inherited metabolic disorder. - This enzyme is responsible for converting **phenylalanine to tyrosine**, not directly involved in melanin synthesis. *Homogentisic acid oxidase* - A deficiency in **homogentisic acid oxidase** causes **alkaptonuria**, a rare metabolic disorder. - This enzyme is involved in the breakdown pathway of **tyrosine and phenylalanine**, causing homogentisic acid accumulation, which results in dark urine and ochronosis. *Decarboxylase* - The term "decarboxylase" refers to a general class of enzymes that remove a **carboxyl group** from a compound. - While decarboxylation reactions occur in many metabolic pathways, no single decarboxylase deficiency is directly responsible for **albinism**.

Q: Which of the following statements about Carbamoyl Phosphate Synthetase I (CPSI) is true?

N-Acetyl Glutamate is an allosteric activator of CPSI.. ***N-Acetyl Glutamate is an allosteric activator of CPSI.*** - **N-acetylglutamate (NAG)** is an essential allosteric activator for **Carbamoyl Phosphate Synthetase I (CPSI)**, signaling a high availability of arginine and a need for urea cycle activity. - Activation by NAG ensures that ammonia is incorporated into the urea cycle only when necessary, preventing its accumulation which can be toxic. *It is present in the cytoplasm.* - **CPSI** is located exclusively in the **mitochondrial matrix** of hepatocytes, where it initiates the urea cycle by converting ammonia to carbamoyl phosphate. - Its cytosolic counterpart, **CPSII**, is involved in pyrimidine synthesis, which differentiates their cellular locations and metabolic roles. *It is involved in pyrimidine synthesis.* - **CPSI** is the rate-limiting enzyme of the **urea cycle**, responsible for detoxifying ammonia by forming carbamoyl phosphate. - **Carbamoyl Phosphate Synthetase II (CPSII)**, located in the cytosol, is the enzyme involved in **pyrimidine synthesis**. *Glutamine is the amino group donor for CPSI.* - **CPSI** uses **free ammonia** (NH3) and **bicarbonate** as substrates to synthesize carbamoyl phosphate, not glutamine. - **Glutamine** is the nitrogen source for **Carbamoyl Phosphate Synthetase II (CPSII)** in pyrimidine synthesis.

Q: Which branched-chain amino acid is the PRIMARY contributor to neurotoxicity in maple syrup urine disease?

Leucine. ***Leucine*** - **Leucine** is the primary branched-chain amino acid (BCAA) responsible for neurotoxicity in **maple syrup urine disease (MSUD)** due to its high concentration in the brain, especially in immature brains. - High levels of leucine and its ketoacid derivative **alpha-ketoisocaproate** interfere with neurotransmitter synthesis, myelin formation, and cerebral energy metabolism, leading to significant neurological damage. *Valine* - While **valine** is one of the BCAAs that accumulates in MSUD, its contribution to direct neurotoxicity is less pronounced compared to leucine. - **Valine** is essential for protein synthesis and tissue repair but does not exert the same level of direct inhibitory effects on cerebral metabolism as leucine. *Isoleucine* - **Isoleucine** is another BCAA whose levels are elevated in MSUD, but it plays a relatively minor role in the acute neurotoxicity compared to leucine. - Its levels must be monitored during dietary treatment of MSUD, as maintaining proper balance of all three BCAAs is essential for preventing metabolic decompensation. *Phenylalanine* - **Phenylalanine** is an aromatic amino acid, not a branched-chain amino acid, and its elevated levels are characteristic of **phenylketonuria (PKU)**, not MSUD. - High phenylalanine causes neurotoxicity in PKU through different mechanisms, distinct from the BCAA-related toxicity seen in MSUD.

Q: HHH syndrome is due to a defect in which transporter?

Ornithine transporter. ***Ornithine transporter*** - HHH syndrome, or **hyperornithinemia-hyperammonemia-homocitrullinuria syndrome**, is caused by a defect in the mitochondrial ornithine transporter, **ORNT1** (also known as SLC25A15). - This deficiency leads to impaired transport of **ornithine** into the mitochondria, disrupting the **urea cycle** and resulting in the characteristic metabolic abnormalities. *Tryptophan transporter* - Deficiencies in tryptophan transporters are associated with conditions like **Hartnup disease** (impaired absorption in the intestine and reabsorption in the kidney). - This condition presents with symptoms related to **niacin deficiency**, such as pellagra-like skin rashes, ataxia, and psychiatric disturbances, which are distinct from HHH syndrome. *Histidine transporter* - Defects in histidine transporters are not typically associated with HHH syndrome. - Impaired histidine transport is linked to conditions causing **histidinemia**, characterized by elevated histidine levels in blood and urine, but not the hyperammonemia or homocitrullinuria seen in HHH syndrome. *Branched chain amino acid transporter* - Deficiencies in branched-chain amino acid (BCAA) transporters are primarily associated with conditions like **Maple Syrup Urine Disease (MSUD)**. - MSUD involves the accumulation of BCAAs and their keto acids, leading to neurological damage, but does not present with the specific metabolic profile of HHH syndrome.

Question 1

A 5-year-old girl with global developmental delay, hypotonia, and failure to thrive presents with severe hyperammonemia. Laboratory results show increased orotic acid, increased glutamine, and decreased BUN. Evaluate and determine the underlying metabolic disorder.

Accepted Answer

Ornithine transcarbamylase deficiency (OTC deficiency)

Answer

Maple syrup urine disease (MSUD)

Answer

Phenylketonuria (PKU)

Answer

Methylmalonic acidemia (MMA)

Question 2

Ochronosis is due to the accumulation of?

Accepted Answer

Homogentisic acid

Answer

Alkapton

Answer

Xanthurenate

Answer

Glyoxylate

Question 3

What is the primary methyl donor in the conversion of norepinephrine to epinephrine?

Accepted Answer

S-adenosyl methionine

Answer

Arginine

Answer

Phenylalanine

Answer

Methionine

Question 4

Phenylketonuria is due to deficiency of:

Accepted Answer

Phenylalanine hydroxylase (PAH)

Answer

Phenylalanine (amino acid)

Answer

Tyrosine

Answer

None of the options

Question 5

In which condition is Vanillylmandelic Acid (VMA) excreted in urine?

Accepted Answer

Pheochromocytoma

Answer

Alkaptonuria

Answer

Neuroblastoma

Answer

Cushing's syndrome

Question 6

Amino acid metabolism is implicated in which disease?

Accepted Answer

Maple syrup urine disease

Answer

Reye's syndrome

Answer

Von Gierke's disease

Answer

McArdle's disease

Question 7

Albinism is due to deficiency of the following enzyme?

Accepted Answer

Tyrosinase

Answer

Phenylalanine hydroxylase

Answer

Homogentisic acid oxidase

Answer

Decarboxylase

Question 8

Which of the following statements about Carbamoyl Phosphate Synthetase I (CPSI) is true?

Accepted Answer

N-Acetyl Glutamate is an allosteric activator of CPSI.

Answer

It is present in the cytoplasm.

Answer

It is involved in pyrimidine synthesis.

Answer

Glutamine is the amino group donor for CPSI.

Question 9

Which branched-chain amino acid is the PRIMARY contributor to neurotoxicity in maple syrup urine disease?

Accepted Answer

Leucine

Answer

Isoleucine

Answer

Valine

Answer

Phenylalanine

Question 10

HHH syndrome is due to a defect in which transporter?

Accepted Answer

Ornithine transporter

Answer

Histidine transporter

Answer

Tryptophan transporter

Answer

Branched chain amino acid transporter

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?